Z Geburtshilfe Neonatol 2021; 225(02): 146-154
DOI: 10.1055/a-1338-0461
Originalarbeit

Der Insulin-Unterschied von Jungen und Mädchen bei Geburt

Insulin Difference of Boys and Girls at Birth
Hans Gottfried Simon
1   Gynäkologie und Geburtshilfe, Walburga Krankenhaus, Meschede, Deutschland
› Author Affiliations

Zusammenfassung

Einleitung Ob Mädchen bei Geburt höhere Insulinspiegel haben als Jungen ist umstritten. Klärung sollen die Insulinwerte von 863 in Folge geborenen Kindern bringen, deren Mütter kein Screening auf Gestationsdiabetes hatten.

Methodik Nabelschnurserum, mit einem handelsüblichen Insulintest bestimmt, wird retrospektiv auf geschlechtsabhängige Insulinunterschiede untersucht.

Ergebnisse Mädchen zeigen höhere Medianwerte als Jungen (♀6,0/♂5,2 µU/ml). Die Insulin-Geschlechts-Differenz beträgt 0,8 µU/ml [95% KI 0,3 bis 1,3], p -Wert 0,003. Sie wird ebenfalls bei AGA-Kindern, bei Neugeborenen von Mehrgebärenden, nach primärer Sectio caesarea und spontaner vaginaler Geburt gefunden (0,8/1,2/1,7/0,9 µU/ml; p-Werte 0,003/0,001/0,025/0,006). Makrosome (LGA/≥4000 g) Mädchen von Mehrgebärenden weisen die höchsten Insulinwerte (13,8/13,8 µU/ml) und die höchste Insulin-Geschlechts-Differenz auf (5,5/5,6 µU/ml, p-Werte 0,001/0,001). Erstgeborene, die weniger als 3640 g wiegen, zeigen diese Insulindifferenz, aber ≥ 4060 g existiert eine inverse Insulin-Geschlechts-Differenz (-5,4 µU/ml; p-Wert 0,023) mit höheren Insulinwerten von Jungen (11,3 µU/ml). Kinder mit Hyperinsulinämie (≥ 20 µU/ml) (17♀/11♂) zeigen keine Insulin-Geschlechts-Differenz, Mädchen wiegen mehr als Jungen (154 g, p-Wert 0,463), Geschwisterkinder 695 g mehr (p-Wert 0,0001) als Erstgeborene.

Schlussfolgerung Höhere Insulinwerte der Mädchen bei Geburt werden bestätigt. Eine bislang nicht bekannte inverse Insulindifferenz mit höheren Insulinwerten makrosomer erstgeborener Jungen wird nachgewiesen.

Abstract

Background Different opinions exist whether girls show higher insulin levels than boys at birth. Insulin values of 863 consecutively born babies whose mothers had no screening for gestational diabetes may provide clarification.

Method Cord serum, measured with a commercially available insulin assay, is therefore retrospectively analyzed for insulin differences in boys and girls.

Results Girls show higher insulin values than boys (♀6.0/♂5.2 µU/ml). Insulin-sex-difference amounts to 0.8 µU/ml [95% CI 0.3 to 1.3]; p-value 0.003. It is also found in AGA babies, in children of multiparous women, after elective caesarean section and spontaneous vaginal delivery (0.8/1.2/1.7/0.9 µU/ml; p-values 0.003/0.001/0.025/0.006). Girls of multiparous women with macrosomia (LGA/≥ 4000 g) show the highest values of insulin (13.8/13.8 µU/ml) and of insulin-sex-difference (5.5/5.6 µU/ml, p-value 0.001/0.001). This insulin difference can be seen in firstborn babies weighing less than 3640 g, but ≥ 4060 g an inverse insulin sex difference (-5.4 µU/ml; p-value 0.023) with higher insulin values in boys exists (11.3 µU/ml). Children with hyperinsulinaemia (≥20 µU/ml) (17♀, 11♂) show no insulin difference, girls weigh more than boys (154 g, p-value 0.463) and later born babies more (695 g, p-value 0.0001) than firstborns.

Conclusion Higher insulin values of girls have been confirmed. An as yet unknown inverse insulin difference with higher insulin values of firstborn boys with macrosomia has been proved.



Publication History

Received: 30 June 2020

Accepted after revision: 07 December 2020

Article published online:
18 January 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Thomson AM, Billewicz WZ, Hytten FE. The assessment of fetal growth. J Obstet Gynaecol Br Commonw 1968; 75: 903-916
  • 2 Shields BM, Knight B, Hopper H. et al. Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. Diabetes Care 2007; 30: 2661-2666
  • 3 Holk A. Erstellung von Referenzwerten für Insulin, C-Peptid und IGF 1 im Nabelschnurserum von Neugeborenen stoffwechselgesunder Mütter. 1994 Diss. FU Berlin
  • 4 Oken E, Morton-Eggleston E, Rifas-Shiman SL. et al. Sex-Specific Associations of Maternal Gestational Glycemia with Hormones in Umbilical Cord Blood at Delivery. Am J Perinatol 2016; 33: 1273-1281
  • 5 Wolf HJ, Ebenbichler CF, Huter O. et al. Fetal leptin and insulin levels only correlate in large-for-gestational age infants. Eur J Endocrinol 2000; 142: 623-629
  • 6 Ibáñez L, Sebastiani G, Lopez-Bermejo A. et al. Gender specificity of adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term-birth: relation to prenatal growth. J Clin Endocrinol Metab 2008; 93: 2774-2778
  • 7 Hellström A, Ley D, Hansen-Pupp I. et al. Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development. Acta Paediatr 2016; 105: 576-586 DOI: 10.1111/apa.13350.
  • 8 Weiss PAM. Diabetes und Schwangerschaft. Wien, New York: Springer; 2002: 81
  • 9 Eder M, Csapo B, Wadsack C. et al. Sex differences in the association of cord blood insulin with subcutaneous adipose tissue in neonates. Int J Obes (Lond) 2016; 40: 538-542 DOI: 10.1038/ijo.2015.185.
  • 10 Ong K, Kratzsch J, Kiess W. et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF - I), IGF - II, IGF-Binding Protein-1 (IGFBP - 1), IGFBPP - 3, and the soluble IBF -II/Mannose - 6 - Phosphate Receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 2000; 85: 4266-4269
  • 11 Higgins M, Mc Auliffe F. A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev 2010; 6: 116-125
  • 12 Thomas K, de Gasparo M, Hoet JJ. Insulin levels in the umbilical vein and in the umbilical artery of newborns of normal and gestational diabetic mothers. Diabetologia 1967; 3: 299-304
  • 13 Schaefer-Graf UM, Rossi R, Bührer C. et al. Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers. Am J Obstet Gynecol 2002; 187: 913-917
  • 14 Holtrop PC. The frequency of hypoglycemia in full-term large and small for gestational age newborns. Am J Perinatol 1993; 10: 150-154
  • 15 Weiss PAM. Diabetes und Schwangerschaft. Wien, New York: Springer; 2002: 554-557
  • 16 HAPO Study Cooperative Research Group. Collaborators: Catalano PM, McIntyre HD, Cruickshank JK. et al. The Hyperglycemia and Adverse Pregnancy Outcome Study: Associations of GDM and obesity with pregnancy outcomes Diabetes Care 2012; 35: 780-786 DOI: 10.2337/dc11-1790.
  • 17 Weiss PAM. Diabetes und Schwangerschaft. Wien, New York: Springer; 2002: 563 Tab.180
  • 18 Simon HG. Eine Reihenuntersuchung auf Hyperinsulinämie bei Geburt. Z. Geburtsh.Neonatol 2014; 218: A5
  • 19 HAPO Study Cooperative Research Group Metzger AR. et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002
  • 20 Gerbitz KD. Pankreatische B-Zellen-Peptide: Kinetik und Konzentration von Proinsulin, Insulin und C-Peptid in Plasma und Urin, Probleme der Messmethoden, klinische Aussage und Literaturübersicht. J Clin Chem Clin Biochem 1980; 18: 313-326
  • 21 O´Rahilly S, Burnett MA, Smith RF. et al. Haemolysis affects insulin but not C-peptide immunosassay. Diabetologia 1987; 30: 394-396
  • 22 Hou RL, Jin WY, Chen XY. et al. Cord blood C-peptide, insulin, HbA1c, and lipids levels in small- and large-for-gestational-age newborns. Med Sci Monit 2014; 20: 2097-2105 DOI: 10.12659/MSM.890929.
  • 23 Godfrey KM, Hales CN, Osmond C. et al. Relation of cord plasma concentrations of proinsulin, 32-33 split proinsulin, insulin and C-peptide to placental weight and the baby's size and proportions at birth. Early Hum Dev 1996; 46: 129-140
  • 24 Wang HS, Lee JD, Soong YK. Effects of labor on serum levels of insulin and insulin-like growth factor-binding proteins at the time of delivery. Acta Obstet Gynecol Scand 1995; 74: 186-193
  • 25 Pirc LK, Owens JA, Crowther CA. et al. Mild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mothers in the ACHOIS randomised controlled trial. BMC Pediatr 2007; 7: 1-8 DOI: 10.1186/1471-2431-7-18.
  • 26 Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H. et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011; 28: 1053-1059 DOI: 10.1111/j.1464-5491.2011.03346.x.
  • 27 Roach VJ, Fung H, Cockram CS. et al. Evaluation of glucose intolerance in pregnancy using biochemical markers of fetal hyperinsulinemia. Gynecol Obstet Invest 1998; 45: 174-176
  • 28 Landon MB, Spong CY, Thom E. et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361: 1339-1348 DOI: 10.1056/NEJMoa0902430.
  • 29 Crowther CA, Hiller JE, Moss JR. et al. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477-2486
  • 30 Persson M, Fadl H, Hanson U. et al. Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes mellitus. Diabetes Care 2013; 36: 3543-3548 DOI: 10.2337/dc13-0899.
  • 31 Weiss PAM. Diabetes und Schwangerschaft. Wien, New York: Springer; 2002: 350 Tab.122
  • 32 Lind T, Gilmore EA, McClarence M. Cord plasma glucose and insulin concentrations and maternal-fetal relations. Br J Obstet Gynaecol 1975; 82: 562-567
  • 33 Stanley KP, Fraser RB, Milner M. et al. Cord insulin and C-peptide -distribution in an unselected population. Br J Obstet Gynaecol 1992; 99: 512-515
  • 34 Shields BM, Spyer G, Slingerland AS. et al. Mutations in the glucokinase gene of the fetus result in reduced placental weight. Diabetes Care 2008; 31: 753-757
  • 35 Jaksić J, Mikulandra F, Perisa M. et al. Effect of insulin and insulin-like growth factor I on fetal macrosomia in healthy women. Coll Antropol 2001; 25: 535-543
  • 36 Hinckers HJ. Glukosestoffwechsel in der Schwangerschaft: Physiologie, Diagnostik, klinische und experimentelle Untersuchungen zur Bedeutung des fetalen Geschlechtes. München, Wien, Baltimore: Urban & Schwarzenberg; 1977: 84 Tab.1
  • 37 Ehtisham S, Hattersley AT, Dunger DB. et al. Arch Dis Child 2004; 89: 526-529
  • 38 Murphy MJ, Metcalf BS, Voss LD. et al. EarlyBird Study (EarlyBird 6). Girls at five are intrinsically more insulin resistant than boys: The Programming Hypotheses Revisited--The EarlyBird Study (EarlyBird 6). Pediatrics 2004; 113: 82-86
  • 39 Wilkin TJ, Murphy MJ. The gender insulin hypothesis: why girls are born lighter than boys, and the implications for insulin resistance. Int J Obes 2006; 30: 1056-1061
  • 40 Leipold H, Kautzky-Willer A, Ozbal A. et al. Fetal hyperinsulinism and maternal one-hour postload plasma glucose level. Obstet Gynecol 2004; 104: 1301-1306
  • 41 Wells JC. Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab 2007; 21: 415-430
  • 42 Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 1954; 16: 330-342
  • 43 Ricart W, López J, Mozas J. et al. Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses. J Epidemiol Community Health 2009; 63: 64-68
  • 44 Retnakaran R, Kramer CK, Ye C. et al. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care 2015; 38: 844-851 DOI: 10.2337/dc14-2551.
  • 45 Barker DJ, Bull AR, Osmond C. et al. Fetal and placental size and risk of hypertension in adult life. BMJ 1990; 301: 259-262
  • 46 Harder T, Rodekamp E, Schellong K. et al. A Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 15.04.2007; 165: 849-857 Epub 2007 Jan 10
  • 47 Yajnik CS, Godbole K, Otiv SR. et al. Fetal programming of type 2 diabetes: is sex important?. Comment on: Diabetes Care 2007; 30: 2661-2666. Diabetes Care 2007; 30: 2754-2755